Cambridge, MA, MONTH, DAY, 2020 – Dyno Therapeutics, a biotech company applying artificial intelligence (AI) to gene therapy today announced two presentations and a poster at the American Society of Gene and Cell Therapy (ASGCT) conference being held May 12-15.

Details are as follows:


Title: Artificial intelligence powered design of synthetic AAV capsids without pre-existing immunity for the universal treatment of all patients

Presenter:  Eric Kelsic, Ph.D., Chief Executive Officer and Co-founder, Dyno Therapeutics
Education Session Title: Synthetic Biology Meets Immunology: DNA and RNA Tools
Date and Time: Tuesday May 12, 2020; 2:40pm – 3:15pm

Title:  Massively Parallel Deep Diversification of AAV Capsid Proteins by Machine Learning
Presenter:  Sam Sinai, Ph.D., Lead Machine Learning Scientist and Co-founder, Dyno Therapeutics
Date and Time: Wednesday May 13, 2020; 4:30pm – 4:45pm
Oral Abstract Session Title: Vector and Cell Engineering, Production or Manufacturing III
Abstract Number: 541


Title: Accurately Quantifying Transduction within Barcoded AAV Capsid Libraries via Tracking of Single-Molecule ID Tags
Presenters: Kathy Lin, Ph.D., Computational Biology Scientist, and Jeff Gerold, Ph.D., Head of Data Science, Dyno Therapeutics
Date and Time: Thursday, May 14, 2020; 5:30pm – 6:30pm
Poster Session Title: AAV Vectors – Virology and Vectorology
Abstract Number: 891

This poster will be available under the Events and Presentations section of the Dyno Therapeutics website at the time of the presentation at

About Dyno Therapeutics
Dyno Therapeutics is a pioneer in applying artificial intelligence to gene therapy. The company’s proprietary platform is built to rapidly discover and systematically optimize superior AAV capsid vectors with delivery properties that transform the gene therapy landscape. Dyno was founded in 2018 by experienced biotech entrepreneurs and leading scientists in the fields of synthetic biology, gene therapy, and machine learning. The company is located in Cambridge, Massachusetts. For additional information, visit the company website at

Back to Top